DENTSPLY SIRONA Inc. Files 8-K on Jan 14, 2025

TL;DR

DENTSPLY SIRONA filed an 8-K on Jan 14, 2025, with updated corporate info.

AI Summary

DENTSPLY SIRONA Inc. filed an 8-K on January 14, 2025, reporting on Regulation FD disclosures and financial statements. The filing confirms the company's principal executive offices are located at 13320 Ballantyne Corporate Place, Charlotte, NC 28277-3607, with a business phone number of (844) 848-0137. The company was incorporated in Delaware and has the IRS Employer Identification Number 39-1434669.

Why It Matters

This 8-K filing provides official updates and disclosures from DENTSPLY SIRONA Inc. to the SEC, which are crucial for investors to stay informed about the company's regulatory compliance and financial reporting.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain any material adverse information.

Key Numbers

• 20250114 — Filing Date (The date the 8-K was filed with the SEC.)
• 0000818479-25-000005 — Accession Number (Unique identifier for this SEC filing.)

Key Players & Entities

• DENTSPLY SIRONA Inc. (company) — Registrant
• January 14, 2025 (date) — Date of Report
• 13320 Ballantyne Corporate Place, Charlotte North Carolina 28277-3607 (address) — Principal Executive Offices
• 0000818479-25-000005 (filing_id) — Accession Number
• 391434669 (tax_id) — IRS Number

FAQ

Key Financial Figures

• $0.01 — ich registered Common Stock, par value $0.01 per share XRAY The Nasdaq Stock Market

Filing Documents

• xray-20250114.htm (8-K) — 27KB
• a2025_jpmhealthcareconfe.htm (EX-99.1) — 23KB
• a2025_jpmbytepressreleas.htm (EX-99.2) — 8KB
• a2025_jpmbytepressreleas001.jpg (GRAPHIC) — 244KB
• a2025_jpmbytepressreleas002.jpg (GRAPHIC) — 283KB
• a2025_jpmhealthcareconfe001.jpg (GRAPHIC) — 95KB
• a2025_jpmhealthcareconfe002.jpg (GRAPHIC) — 262KB
• a2025_jpmhealthcareconfe003.jpg (GRAPHIC) — 116KB
• a2025_jpmhealthcareconfe004.jpg (GRAPHIC) — 93KB
• a2025_jpmhealthcareconfe005.jpg (GRAPHIC) — 103KB
• a2025_jpmhealthcareconfe006.jpg (GRAPHIC) — 115KB
• a2025_jpmhealthcareconfe007.jpg (GRAPHIC) — 127KB
• a2025_jpmhealthcareconfe008.jpg (GRAPHIC) — 108KB
• a2025_jpmhealthcareconfe009.jpg (GRAPHIC) — 96KB
• a2025_jpmhealthcareconfe010.jpg (GRAPHIC) — 120KB
• a2025_jpmhealthcareconfe011.jpg (GRAPHIC) — 102KB
• a2025_jpmhealthcareconfe012.jpg (GRAPHIC) — 133KB
• a2025_jpmhealthcareconfe013.jpg (GRAPHIC) — 78KB
• a2025_jpmhealthcareconfe014.jpg (GRAPHIC) — 42KB
• a2025_jpmhealthcareconfe015.jpg (GRAPHIC) — 217KB
• a2025_jpmhealthcareconfe016.jpg (GRAPHIC) — 43KB
• 0000818479-25-000005.txt ( ) — 3468KB
• xray-20250114.xsd (EX-101.SCH) — 2KB
• xray-20250114_lab.xml (EX-101.LAB) — 21KB
• xray-20250114_pre.xml (EX-101.PRE) — 13KB
• xray-20250114_htm.xml (XML) — 3KB

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure As previously announced, DENTSPLY SIRONA Inc. (the "Company") will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025 (the "Conference"). During the Conference, representatives of the Company will present the materials attached as Exhibit 99.1. A copy of the presentation is being furnished as Exhibit 99.1 to this report. On January 14, 2025, the Company issued a press release relating to updates on its Byte operations. A copy of the press release is being furnished as Exhibit 99.2 to this report. In connection with this decision and the previously announced actions repositioning Byte within the aligner portfolio, the Company expects to incur additional financial impacts in our fourth quarter results including an estimate for customer refunds and potential asset write-offs, which may be material. The Company expects to provide more information on these refunds and write-offs during its fourth quarter and full year 2024 earnings call. The information furnished pursuant to Item 7.01 in this Current Report on Form 8-K, including Exhibit 99.1 and Exhibit 99.2, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference into any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits (d) Exhibits: 99.1 DENTSPLY SIRONA Inc. J.P. Morgan Conference Presentation, dated January 15, 2025 99.2 DENTSPLY SIRONA Inc. Press Release issued January 14, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DENTSPLY SIRONA Inc. By: /s/ Richard C. Rosenzweig Richard C. Rosenzweig Executive Vice President, Corporate Development, General Counsel and Secretary Date: January 14, 2025

View Full Filing

View this 8-K filing on SEC EDGAR